[Complementary Strategy of RSVpreF Vaccination/Nirsevimab versus Nirsevimab Alone for the Prevention of RSV Infection in Infants in Italy: A Cost-Minimization Analysis]. FE [Internet]. 2025 Jul. 29 [cited 2025 Nov. 28];26(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1583